Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

AstraZeneca

Thumbshot of's website
http://www.astrazeneca-us.com

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

Friday 10th of October 2008 8:00

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Google Custom Search
Browse other news from this organisation: AstraZeneca

Related Web-Links

(If any, Generated Automatically)
Google Custom Search

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2008

Download PDF PDF Version

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.